Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for TherapeuticsMD, Inc. (TXMD : NSDQ)

• Company Description    TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. TherapeuticsMD, Inc. is based in Boca Raton, Florida. Number of Employees: 1

• Price / Volume Information    Yesterday's Closing Price: $1.11 Daily Weekly Monthly 20 Day Moving Average: 17,174 shares Shares Outstanding: 11.57 (millions) Market Capitalization: $12.85 (millions) Beta: 0.51 52 Week High: $2.44 52 Week Low: $0.70 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -3.49% -5.24% 12 Week 2.78% -6.69% Year To Date 29.07% 15.24%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 951 Yamato Road Suite 220 - BOCA RATON,FL 33431 USA ph: 561-961-1900 fax: 561-431-3389 ir@therapeuticsmd.com http://www.therapeuticsmd.com

• General Corporate Information    Officers Marlan D. Walker - Chief Executive Officer Tommy G. Thompson - Chairman Joseph Ziegler - Principal Financial and Accounting Officer Cooper C. Collins - Director Gail K. Naughton - Director Peer Information TherapeuticsMD, Inc. (GSAC) TherapeuticsMD, Inc. (CASI) TherapeuticsMD, Inc. (ALCD.) TherapeuticsMD, Inc. (OMNN) TherapeuticsMD, Inc. (CGPI.) TherapeuticsMD, Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 88338N206 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/11/25 Share - Related Items Shares Outstanding: 11.57 Most Recent Split Date: 5.00 (0.02:1) Beta: 0.51 Market Capitalization: $12.85 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/11/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.47 Price/Cash Flow: - Price / Sales: 5.02 EPS Growth vs. Year Ago Period: 155.56% vs. Previous Quarter: 183.33% Sales Growth vs. Year Ago Period: 306.84% vs. Previous Quarter: 142.24% ROE 06/30/25 - -2.01 03/31/25 - -7.86 12/31/24 - -8.35 ROA 06/30/25 - -1.40 03/31/25 - -5.46 12/31/24 - -5.76 Current Ratio 06/30/25 - 2.89 03/31/25 - 2.64 12/31/24 - 2.37 Quick Ratio 06/30/25 - 2.89 03/31/25 - 2.64 12/31/24 - 2.37 Operating Margin 06/30/25 - -21.26 03/31/25 - -116.19 12/31/24 - -131.29 Net Margin 06/30/25 - -17.94 03/31/25 - -114.07 12/31/24 - -123.85 Pre-Tax Margin 06/30/25 - -23.72 03/31/25 - -119.61 12/31/24 - -133.05 Book Value 06/30/25 - 2.36 03/31/25 - 2.31 12/31/24 - 2.37 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©